Equillium, Inc. (EQ)

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth

Equillium (EQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates

Travere (TVTX) delivered earnings and revenue surprises of 0% and 4.10%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

• 
  The Real Brokerage Inc. (REAX) Reports Q3 Loss, Tops Revenue Estimates

  Zacks
• 
  Aadi Bioscience, Inc. (AADI) Reports Q3 Loss, Tops Revenue Estimates

  Zacks